ResearcherNo recent work listed

K.J.F. Satchell

ORCID-verified (high confidence)As of 9 November 2026

Matched on ORCID iD 0000-0003-3274-7611; OpenAlex author ID A5021165682.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Collaborators: 4

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 1 paper

Papers 2

Proteolytic pan-RAS Cleavage Leads to Tumor Regression in Patient-derived Pancreatic Cancer Xenografts. Last author DOI 10.1158/1535-7163.mct-21-0550 ↗
Anthrax Protective Antigen Retargeted with Single-Chain Variable Fragments Delivers Enzymes to Pancreatic Cancer Cells. Co-author DOI 10.1002/cbic.202000201 ↗

Closest collaborators

The 4 strongest of 4 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Vania Vidimar · 1 shared paper, 2022
- Paper Proteolytic pan-RAS Cleavage Leads to Tumor Regression in Patient-derived Pancreatic Cancer Xenografts. DOI 10.1158/1535-7163.mct-21-0550 ↗
Marco Biancucci · 1 shared paper, 2020
- Paper Anthrax Protective Antigen Retargeted with Single-Chain Variable Fragments Delivers Enzymes to Pancreatic Cancer Cells. DOI 10.1002/cbic.202000201 ↗
Bradley L. Pentelute · 1 shared paper, 2020
- Paper Anthrax Protective Antigen Retargeted with Single-Chain Variable Fragments Delivers Enzymes to Pancreatic Cancer Cells. DOI 10.1002/cbic.202000201 ↗
Alexander R. Loftis · 1 shared paper, 2020
- Paper Anthrax Protective Antigen Retargeted with Single-Chain Variable Fragments Delivers Enzymes to Pancreatic Cancer Cells. DOI 10.1002/cbic.202000201 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.